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rbm9Rbfox RNA binding proteins are implicated as regulators of phylogenetically-conserved alternative splicing
events important for muscle function. To investigate the function of rbfox genes, we used morpholino-
mediated knockdown of muscle-expressed rbfox1l and rbfox2 in zebraﬁsh embryos. Single and double
morphant embryos exhibited changes in splicing of overlapping sets of bioinformatically-predicted rbfox
target exons, many of which exhibit a muscle-enriched splicing pattern that is conserved in vertebrates.
Thus, conservation of intronic Rbfox binding motifs is a good predictor of Rbfox-regulated alternative splicing.
Morphology and development of single morphant embryos were strikingly normal; however, muscle develop-
ment in double morphants was severely disrupted. Defects in cardiac muscle were marked by reduced heart
rate and in skeletal muscle by complete paralysis. The predominance of wavy myoﬁbers and abnormal thick
and thin ﬁlaments in skeletal muscle revealed that myoﬁbril assembly is defective and disorganized in double
morphants. Ultra-structural analysis revealed that although sarcomeres with electron dense M- and Z-bands
are present in muscle ﬁbers of rbfox1l/rbox2 morphants, they are substantially reduced in number and align-
ment. Importantly, splicing changes and morphological defects were rescued by expression of morpholino-
resistant rbfox cDNA. Additionally, a target-blocking MO complementary to a single UGCAUG motif adjacent to
an rbfox target exon of fxr1 inhibited inclusion in a similar manner to rbfox knockdown, providing evidence
that Rbfox regulates the splicing of target exons via direct binding to intronic regulatory motifs. We conclude
that Rbfox proteins regulate an alternative splicing program essential for vertebrate heart and skeletal muscle
functions.her), jgconboy@lbl.gov
nc.Published by Elsevier Inc.Introduction
Alternative splicing of pre-mRNAs generates enormous proteome
diversity in metazoans, allowing great complexity to be encoded by
a small repertoire of genes (Nilsen and Graveley, 2010). A subset of
alternatively spliced exons is subject to tightly regulated switches
that activate inclusion or exclusion in spatio-temporally regulated
pattern(s), indicating the existence of tissue-speciﬁc alternative splic-
ing programs. In heart and skeletal muscles, alternative splicing likely
plays a critical role in muscle speciﬁcation and/or function (Bland etal., 2010; Das et al., 2007; Hirata et al., 2007; Pan et al., 2008; Wang
et al., 2008; Xu et al., 2002), and aberrations in splicing are prominent
features of muscle diseases such as muscular dystrophy (DMD) and
spinal muscular atrophy (SMA) (Cooper et al., 2009).
Alternative splicing decisions are regulated by interactions
between cis-acting intronic and exonic elements of the pre-mRNA
with trans-acting splicing regulatory proteins and RNA. Rbfox pro-
teins are unique among splicing factors in that they bind the motif
(U)GCAUG with high speciﬁcity (Auweter et al., 2006; Jin et al.,
2003; Ponthier et al., 2006), suggesting that they target speciﬁc sub-
sets of regulated alternative exons. (U)GCAUG motifs are enriched
in proximal downstream introns of muscle-speciﬁc alternative
exons (Bland et al., 2010; Das et al., 2007; Sugnet et al., 2006;
Zhang et al., 2008), indicating that Rbfox is likely an important com-
ponent of the muscle splicing program.
The zebraﬁsh is an excellent model for human muscle disease due
to its rapid and external development, the ease of experimental
manipulation, live cell imaging and physiology, the possibility of
252 T.L. Gallagher et al. / Developmental Biology 359 (2011) 251–261small molecule screens, and the ease of genetic manipulation (Guyon
et al., 2007; Ingham, 2009). In addition, there are many recognized
similarities between the mammalian, avian, and ﬁsh myogenic
programs (Buckingham and Vincent, 2009; Rochlin et al., 2010). In
zebraﬁsh, formation of all 30 myotomes is completed by 24 h post-
fertilization (hpf); major transitions in muscle function occur during
the ﬁrst day. At 17–18 hpf, spontaneous muscle contractions are
observed and correlate with initial contact of primary motoneuron
growth cones with muscle cells in anterior somites (Hanneman and
Westerﬁeld, 1989). Anterior slow muscle ﬁbers begin to undergo
dramatic cell shape changes and morphogenesis at this stage, which
in turn impact development of the more abundant fast muscle ﬁbers
(Cortes et al., 2003; Daggett et al., 2007; Devoto et al., 1996; Henry
and Amacher, 2004; Henry et al., 2005). By 28 hpf, slow and fast
muscle differentiation is well underway. The rate of spontaneous coil-
ing diminishes, replaced by more controlled touch-evoked responses
and swimming behaviors, consistent with known changes that are
occurring in both the motor and sensory neural networks (Hirata et
al., 2009). A large number of zebraﬁsh motility mutants, many of
which have now been molecularly identiﬁed and represent new
models of human disease, provide a basic framework outlining the
speciﬁc developmental processes and molecules required for muscle
function (Chong et al., 2009; Granato et al., 1996). One challenge
remaining is to understand how changes in tissue-speciﬁc splicing
programs, that globally inﬂuence production of many downstream
isoforms, modulate muscle development and function.
We hypothesized that Rbfox proteins promote muscle identity
and/or function by inﬂuencing alternative pre-mRNA splicing events
in heart and skeletal muscles. Here we show that zebraﬁsh Rbfox1l
and Rbfox2 regulate an alternative splicing program that is essential
for normal muscle function during zebraﬁsh embryogenesis.
Materials and methods
Bioinformatics
Zebraﬁsh exons orthologous to human muscle-enriched exons
were identiﬁed using genome alignments at the UCSC genome
browser (http://genome.ucsc.edu). Additional candidate Rbfox-
regulated exons were deﬁned by comparative genomics among
teleosts using text searches and the UCSC Genome Bioinformatics
website as described previously (Garnett et al., 2009) to identify
introns in multiple ﬁsh species that contained UGCAUG hexamers
within 1 kb of annotated orthologous exons.
Animal stocks and husbandry
Wild-type (AB strain) and transgenic zebraﬁsh embryos (Danio
rerio) were obtained from natural spawnings of adult ﬁsh kept at
28.5 °C on a 14 h light/10 h dark cycle, raised at temperatures
between 22 °C and 30 °C, and staged according to Kimmel et al.
(1995). Transgenic zebraﬁsh lines were Tg(actc1b:GFP (Higashijima
et al., 1997)) and Tg(myl7:GFP (Burns et al., 2005)).
Cell sorting
Tg(actc1b:GFP (Higashijima et al., 1997)) embryos were grown in
embryo medium to 18 hpf and dechorionated by pronase treatment.
Embryos were triturated using a 200 μl pipette and washed to remove
yolks as previously described (Link et al., 2006). De-yolked embryos
were dissociated and resuspended as described previously (Covassin
et al., 2006). Cells were ﬁltered through a 35 um nylon screen by
centrifugation for 3 min at 300×g and sorted by FACS at room tem-
perature under sterile conditions using a DAKO-Cytomation MoFlo
High Speed Sorter. GFP+ and GFP− cells were separately collected in
PBS (5% FCS), centrifuged at 300×g for 5 min and washed with PBS(5% FCS), re-centrifuged at 300×g for 5 min and resuspended in
300 μl Trizol (Invitrogen). We obtained 1×105 GFP+ cells, yielding
500 ng of total RNA, from approximately 100 Tg(actc1b:GFP) embryos.
Splicing analysis
Whole embryos, dissected tissues, and sorted cells were solubi-
lized in Trizol (Invitrogen). RNA was puriﬁed and reverse transcribed
with Superscript III reverse transcriptase (Invitrogen) according to
the manufacturer. For a subset of transcripts that were expressed at
low levels, gene-speciﬁc primers were used for ﬁrst strand synthesis.
Semi-quantitative PCR was performed with primers complementary
to ﬂanking exons as described previously (Ponthier et al., 2006).
Levels of isoform-speciﬁc expression were determined by comparison
of inclusion and exclusion product intensities for each sample using
Alpha View SA 3.2.2 software (Cell Biosciences, Inc). Primer
sequences used and alternative exon sizes are listed in Supplementary
Table S1.
In situ hybridization
Wholemount in situ hybridization was performed as previously de-
scribed (Jowett, 1999) using DIG-labeled antisense probes for rbfox1l
and rbfox2 cDNA. A 1.1 kb fragment of the rbfox1l cDNA was ampliﬁed
by RT-PCR using forward and reverse primers 5′-ATGTTGTCTTCTCC-
TACTGTGATCC-3′ and 5′-TCAGTATGGTGTGAAGCGGTTGTA-3′, sub-
cloned into pCMV Sport6.1 (Invitrogen), linearized with Not I, and
transcribed using Sp6 RNA polymerase to make DIG-labeled antisense
rbfox1l riboprobe. The rbfox2 cDNAwas ampliﬁed byRT-PCR using a for-
ward primer (5′-GATTGCTGCGTCTTCAGGAG-3′) complementary to
sequence within cDNA clone CA496690A (containing N-terminal rbfox2
sequence) and a reverse primer (5′-AGAGACGGAAATCTGGAAGTG-3′)
complementary to sequence within cDNA clone BC068360 (a long
rbfox2 cDNA clone that lacks N-terminal sequence upstream of the RRM
domain). The resulting 1.4 kb fragment of the rbfox2 cDNA (Table S2)
was subcloned into pBSKS (Stratagene), linearized with EcoR1, and tran-
scribed using T7 RNA polymerase to make DIG-labeled antisense rbfox2
riboprobe.
Antisense-mediated knockdown and rescue
All MOs were synthesized by Gene Tools, LLC. rbfox1l sbMO
sequences are 5′-gcatttgttttacCCCAAACATCTG-3′ (exon 3 junction)
and 5′-ttatcattgtcatacCTCAATCTTC-3′ (exon 5 junction). rbfox2
sbMO sequences are 5′-tataatgctttatatacCCCGAACA-3′ (exon 3 junc-
tion) and 5′-aaagagagaaagactgacCTCGATC (exon 5 junction). The
fxr1 target-blocking MO sequence is 5′-aggaaaacacagcacatgtcatgca-
3′ (underlined sequence corresponds to the Rbfox motif). Sequences
complementary to exons are shown in uppercase while intronic com-
plementary sequences are shown in lowercase. MOs were diluted to a
ﬁnal concentration of 1.5–3 ng/nl in 0.2 M KCl and 0.1% phenol red
and injected into the yolk of 1-cell stage embryos. Optimal MO dose
(12 ng rbfox1l MO; 12 ng rbfox2 MO, and 6 ng rbfox1l MO+6 ng
rbfox2 MO) was determined by testing MO doses, ranging from 1 to
15 ng and choosing a dose that gave reproducible and rescuable phe-
notypic defects with no toxicity. Embryos were incubated at 28.5 °C
and assayed at multiple time points over 2 days. For rescue experi-
ments, rbfox2 mRNA was synthesized using the T3 mMessage
mMachine Kit (Ambion), diluted in 0.2 M KCl with 0.1% phenol red,
and injected directly into 1-cell stage embryos (10–200 ng mRNA
per embryo) with or without rbfox sbMOs.
Immunohistochemistry
Immunostaining of embryos at various developmental stages was
performed as previously described (Panzer et al., 2005). F59
Fig. 1. Muscle-enriched splicing of predicted Rbfox-regulated target exons. Semi-
quantitative RT-PCR splicing analysis reveals 12 representative alternative exons that
are better included in trunk/tail (largely muscle) than head (muscle-poor) fractions
at 24 h post fertilization (hpf), as well as in FACS-puriﬁed GFP+ muscle versus GFP−
cells from actc1b:GFP embryos at 24 hpf. Subsequent analyses show that splicing of
8 of the 12 exons (the top two rows) shown is regulated by rbfox1l and/or rbfox2.
Upper product=inclusion isoform; lower product=exclusion isoform. PCR primers
and expected band sizes for inclusion and exclusion isoforms are listed in Supplementary
Table S1.
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Hybridoma Bank (DSHB) (Miller et al., 1985)) was used at 1:20
dilution (Devoto et al., 1996), Alexa Fluor 488 conjugated
α-bungarotoxin (Invitrogen) was used at 10 μg/ml following manu-
facturer's instructions, SV2 (monoclonal anti-synaptic vesicles, DSHB
(Buckley and Kelly, 1985)) secondarily bound to Alexa Fluor 546 con-
jugated antibody (Molecular Probes) was used at 1:100 dilution, and
Alexa Fluor 488 conjugated phalloidin (Invitrogen) was used at
1 unit/ml following manufacturer's instructions.
Light microscopy
Live embryoswere placed in embryomedium containing 0.004% tri-
caine, mounted in 4% methylcellulose, and imaged using an Axiocam
digital camera with a Leica MZFLIII stereoscope, AxioPlan2 microscope,
and/or Zeiss 5-LIVE Fast Scanning Confocal Microscope. Fixed embryos
weremounted in permount and captured using an AxiocamHRc digital
camerawith AxioPlan2microscope,mounted in 4%methylcellulose and
imaged with a Zeiss 510 AxioPLAN META Confocal microscope, or
mounted in 75% glycerol and imaged with a Zeiss LSM 780 AxioExami-
ner Confocal microscope. Images were processed with LSM Image
Browser v4.2, Image J v1.44, and/or Adobe Photoshop CS4 v11.0.2.
Electron microscopy
Live embryos were placed in embryo medium containing 0.004%
tricaine and transferred to a dish containing 2.5% glutaraldehyde ﬁx-
ative in 0.1 M Milonig's phosphate buffer, pH 7.2 (Electron Microsco-
py Sciences Cat. No. 15970) and the tails cut off just behind the yolk
sac. The last few segments of the tail were also cut off. Four central
tail segments were transferred to 1 ml of glutaraldhyde ﬁxative in a
2 ml Eppendorf tube and 4 drops of 4% aqueous osmium tetroxide
(Electron Microscopy Sciences Cat. No. 19150) were added. Subse-
quent processing was done in volumes of 1 ml in a Pelco Biowave®
Pro Research Microwave (Ted Pella, Inc., Prod. No. 36500). Fixations
steps were done at 150 W under vacuum (20 in.Hg) for 1 min on,
1 min without microwaves, then another min on. Samples were
rinsed outside the microwave with 0.1 M phosphate buffer 2 times
3 min, then 3 times 3 min with dH2O. An en bloc 2% aqueous uranyl
acetate incubation was done for 3 min at 150 W under vacuum. Dehy-
dration was done at 2 times 40 s each in an acetone series of 25, 50,
70, 75, 90, and 95%, followed by 5 times 40 s each with pure acetone
(Electron Microscopy Sciences Cat. No. 10015). Inﬁltration with Epon
resin was done under vacuum at 2 times 3 min at 350 W in acetone/
resin mixtures of 25, 50, and 75% followed by 3 times 3 min of pure
resin at 350 W. Resin polymerization was in ﬂat-bottomed polypro-
pylene capsules (Ted Pella, Inc., Prod. No. 133-P) secured in a
PELCO® Microwave Capsule Holder (Ted Pella, Inc., Prod. No.
36133) and microwaved underwater for 7 min at 350 W, 7 min at
450 W, 7 min at 550 W, followed by 50 min at 750 W. More details
about microwave processing for electron microscopy can be found
at: http://www.tedpella.com/microwave_html/EM-proto.htm.
Thin sections (70 nm) were cut on a Reichert-Jung Ultracut E ultra-
microtome (C. Reichert Optische Werke AG, Vienna, Austria), post-
stained for 4 min in 2% uranyl acetate in 70% methanol, 2 min in lead
citrate, and viewed on an FEI Tecnai 12 transmission electron micro-
scope (FEI, Hillsboro, OR) operated at 120 kV. Images were recorded
on a Gatan Ultrascan 1000 digital camera (Gatan, Inc., Pleasanton, CA).
Results
Muscle-enriched splicing events are conserved in vertebrates
Exon microarray and RT-PCR experiments have identiﬁed numer-
ous muscle-enriched splicing events, many of which have been con-
served throughout vertebrate evolution at least from birds tomammals (Bland et al., 2010; Das et al., 2007; Sugnet et al., 2006).
To identify muscle-enriched exons in zebraﬁsh that are candidates
for regulation by Rbfox proteins, we compiled a list of zebraﬁsh
exons that are orthologs of mammalian muscle-enriched exons, or
that possess conserved Rbfox sites in the ﬂanking introns, or both
(Supplementary Table S1; (Das et al., 2007; Zhang et al., 2008)).
We evaluated alternative splicing efﬁciency of candidate muscle-
enriched exons using semi-quantitative RT-PCR analysis of RNA har-
vested from dissected embryonic head versus tail tissue at 24 h
post-fertilization (hpf), when differentiated muscle is not yet present
in the head, but is enriched in the tail (Kimmel et al., 1995). Indepen-
dently, splicing analysis was performed on RNA isolated from embry-
onic muscle cells puriﬁed by ﬂuorescence-activated cell sorting
(FACS) from actc1b:GFP transgenic embryos that express GFP exclu-
sively in developing and mature skeletal muscle (Higashijima et al.,
1997). Both assays revealed muscle-enriched splice patterns for 12
exons (Fig. 1). An additional 10 exons with ﬂanking Rbfox binding
site(s) were alternatively spliced in both non-muscle and muscle-
enriched fractions (data not shown). Collectively, the candidate
gene approach yielded a set of 22 alternative exons in zebraﬁsh
muscle that were potentially regulated by Rbfox splicing regulators.
Two zebraﬁsh rbfox homologs are expressed in muscle
The zebraﬁsh rbfox1l gene (fox-1/a2bp1l, Ch16; Entrez Gene:
406569) encodes an RNA binding protein that recognizes intronic
(U)GCAUG motifs and exhibits alternative splicing regulatory activity
in minigene assays (Jin et al., 2003). We identiﬁed three additional
rbfox paralogs in the zebraﬁsh genome, designated rbfox1 (a2bp1,
Chr3; Entrez Gene: 449554), rbfox2 (rbm9, Chr6; Entrez Gene:
407613), and rbfox3 (Chr3; Entrez Gene: LOC559412) based on
amino acid sequence similarity and similar gene structure with
rbfox1l. The predicted protein products of these zebraﬁsh genes all
exhibit greater than 50% similarity to human RBFOX1, RBFOX2, and
RBFOX3, with N90% amino acid sequence identity in their RNA recog-
nition motifs (RRM).
rbfox expression was analyzed by in situ hybridization to identify
which paralogs might regulate muscle splicing events during early
development. rbfox1l is expressed exclusively in skeletal and cardiac
muscles at all stages examined (Fig. 2A–G). rbfox1l is expressed at
the onset of segmentation in adaxial cells (Fig. 2A), the precursors
to slow-twitch muscle ﬁbers (Devoto et al., 1996). By the 14 somite
stage, rbfox1l is expressed in the bilateral wings of pre-cardiac meso-
derm (Fig. 2C). Expression persists throughout somitogenesis and is
restricted to anterior presomitic mesoderm (PSM), the posterior
domain of formed somites, and adaxial cells (Fig. 2D). At 24 hpf and
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ing the muscles of the head and pectoral ﬁn, and in the embryonic
heart (Fig. 2E–G; E′ indicates expression in the cardiac cone). These
data corroborate and extend previous studies of rbfox1l expression
(Baxendale et al., 2009; Jin et al., 2003). Like rbfox1l, rbfox2 is
expressed in myogenic cells, particularly in the PSM and in newly
formed somites (Fig. 2I,J), however rbfox2 is much more broadly
expressed than rbfox1l (compare Fig. 2A–G with 2H–N) and is also
detected in other tissue types, including neural tissues, particularly
at later stages (Fig. 2L–N). In contrast to rbfox1l and rbfox2, rbfox1 is
expressed predominantly in neural tissues and not in muscle
(Fig. S1), consistent with previous studies showing strong neural expres-
sion through the ﬁrst 5 days of development (Kurrasch et al., 2007;
Thisse, 2004). rbfox3 transcripts were not detectable by in situ hybridiza-
tion. Together, these data suggested that the rbfox genes most likely
involved in a muscle-speciﬁc splicing program were rbfox1l and rbfox2.
Knockdown of rbfox1l and rbfox2 expression alters splicing of predicted
alternative exon targets in muscle
To test the hypothesis that rbfox1l and rbfox2 regulate a
functionally-relevant, muscle-speciﬁc alternative splicing program,
we used an antisense-mediated knockdown strategy to assess
splicing and phenotypic changes after Rbfox knockdown. Since
Rbfox orthologs in mouse and human contain multiple translation ini-
tiation sites encoded within alternative ﬁrst exons (Nakahata and
Kawamoto, 2005; Underwood et al., 2005), we used splice-blocking
MOs (sbMOs) to ensure targeting of all zygotic rbfox transcripts.
Furthermore, injection of translation-blocking MOs targeting rbfox1l,
even at low doses, resulted in substantial lethality by gastrulationFig. 2. Zebraﬁsh rbfox1l and rbfox2 are expressed in muscle cells. rbfox1l (A–G) and rbfox2 (H–N
and lateral (B, E, F, J–M) views. rbfox1l is expressed in adaxial slowmuscle precursor cells (arrow
(small arrows in B, D, E), cardiac mesoderm (B, C, E, E′) and pectoral ﬁn (large arrows in F, G),
broadly, with enrichment in the PSM and newly formed somites (small arrows in I–K) at early t
expression decreases as somitesmature (K, L). By 36 hpf, rbfox2 transcripts are detected predom
dorsal view, of the boxed region in B. Scale bar=200 um for all panels except C (100 um).stages, precluding muscle phenotypic analysis at later stages and sug-
gesting that maternally-derived rbfox1l transcripts might be critical
for embryonic survival (Table S3). Consistent with this idea, we
detected maternally-provided rbfox1l (and rbfox2) transcripts during
cleavage stages prior to the onset of zygotic transcription (Fig. S2).
All sbMOs were directed against Rbfox RRM-coding exons in order
to disrupt RNA binding. Injection of sbMOs directed against 5′ splice
sites of exon 3 in rbfox1l and rbfox2 transcripts activated cryptic splice
sites either in the exon (rbfox1l) or in the adjacent intron (rbfox2) to
produce aberrant, frameshifted mRNAs with premature termination
codons (Fig. S3). Similar reductions in wild type transcript abundance
were also induced by sbMOs directed against exon 5 (results not
shown). The effects of all sbMOs tested were gene-speciﬁc; sbMOs
targeting rbfox1l did not alter the structure of rbfox2 transcripts and
vice versa (Fig. S3). After establishing that rbfox1l and rbfox2 exon 3
and exon 5-targeting MOs produce identical or similar results (see
below), exon 3 sbMOs were used in subsequent experiments unless
otherwise noted.
To determine whether muscle-speciﬁc alternative splicing of
candidate rbfox-regulated exons was developmentally regulated, we
examined splicing during normal zebraﬁsh development between
17 and 70 hpf (Fig. S4). Because some alternative splicing events did
exhibit developmental changes in splicing efﬁciency, splicing
analyses of rbfox morphants were performed at 28 hpf (Fig. 3), a
time point at which the majority of candidate exons had relatively
stable splicing inclusion levels. Single morphants exhibited reduced
splicing efﬁciency in non-overlapping subsets of target exons
(Fig. 3A–B). Double rbfox1l/rbfox2 morphants displayed the same
splicing changes as single morphants, as well as alterations in three
additional exons (Fig. 3C). Splicing data were quantiﬁed using three) expression between the 1-somite stage and 42 hpf are shown in dorsal (A, C, D, G–I, N)
head in A, D), the anterior presomiticmesoderm (PSM; asterisk in D) and formed somites
hypaxial body wall (bracket in G), and head musculature (F, G). rbfox2 is expressed more
imes (H–N). Strong rbfox2 expression is detected in the tail bud (J–L), but myogenic rbfox2
inantly in the head and pectoral ﬁn (large arrows inM, N). Panel C is amagniﬁed image, in
Fig. 3. Rbfox knockdown reveals three classes of regulated exons. Semi-quantitative
RT-PCR splicing analysis of candidate target exons revealed exon skipping upon knock-
down of rbfox1l (A), rbfox2 (B), or both rbfox genes (C). (D) An MO targeting the single
Rbfox binding motif in the fxr1 intron reduced exon inclusion to a similar extent as
knockdown of rbfox1l expression (A). All results were reproducible in at least 3 exper-
iments (average exon inclusion levels noted below each gel). Alternative exon (black),
constitutive exons (gray), Rbfox1l protein (black oval), Rbfox UGCAUG binding motif
(black rectangle). In all panels, WT=mock-injected embryos except in D, WT=unin-
jected embryos, MO=morpholino, E=exon, Incl=inclusion. PCR primers and
expected band sizes for inclusion and exclusion isoforms are listed in Supplementary
Table S1.
Fig. 4. Rbfox1l/Rbfox2 knockdown results in cardiac and skeletal muscle defects. (A, B)
In Rbfox doublemorphants, myotomes are chevron-shaped as in control embryos (lateral
view, one myotome is false-colored in each panel). (C–H) Polarized light microscopy
reveals that rbfox1l/rbfox2morphantmuscle has delayed birefringence at 30 hpf (compare
C with D) that partially recovers by 48 hpf (compare E with F). (G–I) Rbfox1l/Rbfox2
knockdown inmyl7-GFP embryos that haveGFP+myocardial cells, reveals cardiacmuscle
defects, with low rbfox1l/rbfox2 MO doses (1.5 ng each) causing ventricular defects and
high doses (9 ng each) affecting themorphology of the entire heart. WT=mock-injected;
MO=morpholino; a=atrium; v=ventricle. Scale bars=100 um (A–B; G–I), 500 um (C–F).
255T.L. Gallagher et al. / Developmental Biology 359 (2011) 251–261or more biological replicates (Fig. S5). rbfox1/rbfox2 knockdown affect-
ed splicing of the appropriate rbfox exon, as well as rbfox-regulated tar-
get exons, in a dose dependent manner (Fig. S6). To further establish
speciﬁcity, p53 MO co-injection was performed and the same splicing
differences were observed when compared to rbfox1l/rbfox2 MO injec-
tion alone (Fig. S6; data not shown) (Robu et al., 2007), whereas injec-
tion of an sbMO targeting neurally-expressed rbfox1 transcripts had no
effect on the splicing of these same candidate exons (Fig. S7).
In total, 15 of the 22 candidate Rbfox-regulated alternative exons
exhibited lower splicing efﬁciency in rbfox1l/rbfox2 double mor-
phants (Fig. S8). Control experiments showed that similar splicing
changes to those observed with rbfox1l exon 3 sbMOs were induced
by sbMOs targeting rbfox1l exon 5, but not by sbMOs targeting the
neurally-expressed rbfox1 (data not shown; Fig. S7). Similarly,
embryos injected with rbfox2 exon 5 sbMOs showed the same splic-
ing changes as those induced by rbfox2 exon 3 sbMOs, in addition to
changes of 4 additional exons (data not shown). Embryos injected
with rbfox2 exon 5 sbMOs had delayed development, a bent tail,
somite boundary defects, and reduced motility (data not shown).
Unlike exon 3 sbMOs, where the aberrantly spliced transcript encodes
a truncated protein due to frameshift, rbfox2 exon 5 sbMOs inducecomplete exon 5 skipping, generating an in frame deletion (data not
shown). The protein encoded by this aberrant transcript likely acts
in a dominant-negative fashion, analogous to that reported in
mouse Rbfox2 lacking the equivalent exon (Damianov and Black,
2009).
Rbfox regulation requires an intronic UGCAUG splicing enhancer
To test whether Rbfox-regulated splicing operates via UGCAUG
intronic enhancers, we designed a target-blocking MO complementary
to the single UGCAUG motif in the proximal downstream intron of the
fxr1 alternative exon (Fig. 3D). Consistent with our ﬁnding that a vivo-
MO against intronic Rbfox motifs can reduce splicing efﬁciency in the
mouse (Parra et al., 2011), an fxr1 target-blocking MO signiﬁcantly
inhibited exon inclusion in zebraﬁsh (Fig. 3D). This result strongly
supports that Rbfox1l modulates fxr1 exon inclusion via binding to the
UGCAUG motif.
Rbfox1l and Rbfox2 are critical for motility, myoﬁbril organization, and
normal heart function
Knockdown of either rbfox1l or rbfox2with exon 3-targeting MOs did
not cause gross morphological or physiological defects in developing
embryos. In contrast, rbfox1l/rbfox2 double morphant embryos have
severe defects in skeletal and cardiac muscle functions (Figs. 4–6; 8–9;
S9). Double morphants were completely paralyzed (pb1.0×10−4,
n=60), lacking normal spontaneous coiling (17–19 hpf), touch-evoked
256 T.L. Gallagher et al. / Developmental Biology 359 (2011) 251–261contractions (24 hpf), and swimming movements (28+hpf). Double
morphant cardiac muscle exhibited dose-dependent morphological
defects (Fig. 4G–I) and signiﬁcantly reduced heart rate compared to
mock-injected controls (pb1.0×10−4, n=48).
Chevron shaped myotomes appear grossly normal in paralyzed
rbfox1l/rbfox2morphants (Fig. 4A, B), however, upon closer examina-
tion, dramatic myoﬁbrillar defects were observed. In control embryos,
polarized light microscopy revealed substantial birefringence, indi-
cating organized myoﬁbrillar organization at 30 hpf, but onset of
muscle birefringence in rbfox1l/rbfox2 morphants was signiﬁcantly
delayed (Fig. 4C–F). Myosin heavy chain (MHC) localization, revealed
by F59 immunohistochemistry that identiﬁes strongly staining slow-
twitch and weaker staining fast-twitch muscle ﬁbers, was strikingly
abnormal in rbfox1l/rbfox2 morphants at all stages of ﬁber develop-
ment examined (Fig. 5A–D; data not shown) (Devoto et al., 1996).
Phalloidin labeling of thin ﬁlaments revealed that although F-actin
was present in muscle ﬁbers of rbfox1l/rbfox2morphants, the normal-
ly striated myoﬁbrillar arrangement at 24 hpf was largely absent and
by 48 hpf, ﬁbers were present but they appeared wavy andFig. 5. Rbfox1l/rbfox2 knockdown alters myoﬁbril organization. (A–D) Anti-MHC
immunohistochemistry at 24 and 48 hpf reveals that slow muscle ﬁbers in rbfox1l/
rbfox2morphants are disorganized compared to normally striated ﬁbers inwildtypemus-
cle (A, C vs. B, D). (E–J) Immunohistochemistry with Alexa-Fluor 488-conjugated phalloi-
din, which labels F-actin, reveals that slow and fast muscle thin ﬁlaments are elongated
and highly organized in wildtype embryos at 24 and 48 hpf, respectively (E, G), whereas
thin ﬁlament structure is severely disrupted in Rbfox1l/rbfox2 morphants (F, H). Defects
in myoﬁber organization (I–J) are less severe at lower rbfox1l/rbfox2 MO doses (1.5 ng
each) when compared to higher doses (7 ng each). Doses in B, D, F, and H=4.5 ng each
MO. Scale bars=50 um.disorganized (Fig. 5G–H). Defects in myoﬁber organization were
less severe at low (1.5 ng each) than high (7 ng each) doses of
rbfox1l/rbfox2 MO (Fig. 5I, J). Knockdown of rbfox1l or rbfox2 alone
did not alter the striated appearance of myoﬁbrils, although ﬁbers
of rbfox1l morphants were mildly affected at doses of 9 ng or above,
whereas combined doses of 4.5 ng each of rbfox1l and rbfox2 sbMOs
resulted in highly disorganized, wavy ﬁbers (Fig. S9).
Ultra-structural analysis also revealed that muscle ﬁbers were
highly disorganized (Fig. 6). Longitudinal sections revealed a substan-
tial reduction in sarcomere number and arrangement as evidenced by
disrupted Z-disk alignment throughout muscle ﬁbers (Fig. 6A–D).
Electron dense M-lines and vesicles of the sarcoplasmic reticulum
appeared diminished and disorganized, respectively (Fig. 6C–D).
Cross-sections of muscle ﬁbers revealed myoﬁbrils with dramatic
reduction in both thick and thin ﬁlament number; additionally, the
orientation of ﬁlaments with respect to each other is largely disrupted
(Fig. 6E–H).Fig. 6. Ultra-structural analysis of rbfox1l/rbfox2morphants reveals disorganized sarco-
meres that are reduced in number. Electron micrographs of longitudinal sections of
48 hpf wildtype muscle at 390× and 6000× magniﬁcation reveal highly ordered sarco-
meres with electron dense Z disks terminating with T-tubules at the sarcoplasmic
reticulum (asterisks in C), which contrasts sharply with the dramatic reduction in sar-
comere number and organization observed in rbfox1l/rbfox2 morphants at the same
magniﬁcation (compare A, C with B, D). In the latter, vesicles of the sarcoplasmic retic-
ulum are disorganized and T-tubules are not observed or are unidentiﬁable at Z-disk
boundaries (asterisk in D). Cross sections at 390× and 4000× reveal defects in overall
muscle ﬁber size as well as thick and thin ﬁlament arrangement between wildtype
embryos and rbfox1l/rbfox2 morphants (E, G vs. F, H). Scale bars=2.0 um (A–B, E–F),
0.2 um (C–D, G–H).
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can cause motility defects (Panzer et al., 2005). Using anti-SV2 and
Alexa Fluor 488 conjugated alpha-bungarotoxin (BTX) to detect pre-
and post-synaptic NMJ components, respectively, we observed that
NMJs in rbfox1l/rbfox2 morphants are virtually indistinguishable
from those in controls (Fig. 7), although there was a minor reduction
in acetylcholine receptor (AChR) clustering in some Rbfox morphants
(Fig. 7J; data not shown). These data support the idea that paralysis in
rbfox1l/rbfox2 morphants is skeletal muscle cell-autonomous,
although it is still possible that neuronal defects contribute to the
phenotype. Future genetic mosaic and electrophysiological experi-
ments will address these issues.
Co-injected rbfox2 mRNA restores all defects arising from rbfox1l/rbfox2
knockdown
Co-injection of MO-resistant wild-type rbfox2 mRNA with rbfox1l
and rbfox2 sbMOs compensated for defects observed in splicing ofFig. 7. Rbfox1l/rbfox2 knockdown does not alter neuromuscular junction structure. Pre- and
anti-SV2 (red) and alpha-bungarotoxin (BTX, green), respectively, appear structurally norm
bar=50 um.candidate exons, even those normally affected only by rbfox1l knock-
down (Fig. 8A). This suggests that rbfox2 can functionally replace
rbfox1l, at least when supplied in excess and/or when expressed in
all cells. Co-injected rbfox2mRNA also restored normal heart function
in rbfox1l/rbfox2 morphants since heart rate was signiﬁcantly elevat-
ed in these embryos compared to morphant embryos lacking rbfox2
mRNA co-injection (pb1×10−4, n=45); morphological defects and
pericardial edema were substantially reduced and heart rate was
not signiﬁcantly different from controls (Fig. 8B–G and data not
shown; p=0.034, n=100). Additionally, skeletal muscle contrac-
tions, which were abolished in Rbfox double morphants, were
completely restored upon rbfox2 mRNA injection (pb1×10−4,
n=63). Contraction rates were slightly elevated relative to control em-
bryos (p=5×10−4, n=124) but no different from rates observed in
rbfox2 mRNA-injected control embryos (Fig. 8H; p=0.98, n=22). As
expected, immunohistochemistry revealed thatmuscle ﬁber organization
was also dramatically restored in rbfox2mRNA-injected doublemorphant
embryos (Fig. 9). Labeling of slowand fastmuscleﬁber components usingpost-synaptic neuromuscular junctions at 30 hpf (A–F) and 36 hpf (G–L), stained with
al (lateral view, A–C, G–I vs. D–F, J–L). WT=mock-injected; MO=morpholino. Scale
Fig. 8. Splicing and physiological defects are rescued with exogenous rbfox2. (A) Splicing analyses of 15 exons that are abnormally spliced upon rbfox1l, rbfox2, or double rbfox1l/rbfox2
knockdown show that normal splicing patterns are restored upon co-injection of MO-resistant rbfox2 mRNA. (B–G) Co-injected rbfox2 mRNA rescued heart-related defects caused by
rbfox1l/rbfox2 knockdown. At 48 hpf, rbfox1l/rbfox2 double morphants exhibit pericardial edema (arrow in C, compare to wildtype embryo in B) that was reduced by co-injection with
rbfox2mRNA (D). Ventral views of the samemyl7-GFP embryos shown in B–D reveal that ventricle morphology of embryos co-injected with rbfox1l/2MOs and rbfox2mRNA (G) are in-
distinguishable fromwild type (E). (H) Functional defects in skeletal muscle and heart in Rbfox doublemorphants, asmeasured bymuscle contractions at 24 hpf and heart rate at 52 hpf,
respectively, are rescued by co-injection of rbfox2mRNA. WT=mock-injected; MOs=rbfox1l+rbfox2MO; MO=morpholino; E=exon; a=atrium; v=ventricle; n=number of indi-
viduals sampled; SE=standard error. Scale bars=500 um (B–D), 100 um (E–G).
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respectively) showed that both slow and fast muscles appear striated in
rbfox2 mRNA-injected double morphant embryos. The persistence of
slightly wavy ﬁbers may correlate with the reduced strength, but notFig. 9. Myoﬁbril defects are rescued with exogenous rbfox2. (A–C) Anti-MHC immunohisto
mRNA-injected double morphant embryos closely resembles wild-type morphology and is
alone, although some wavy ﬁbers persist. (D–I) Similarly, thin ﬁlament structure detected
in both deeper fast muscle and more superﬁcial slow muscle layers of rbfox2 mRNA-injecte
injected with rbfox1l/rbfox2 MOs alone. Scale bar=50 um.frequency, of skeletal muscle contractions observed in these embryos.
Together, these data show that splicing, morphological, and physiological
defects that arise from rbfox1l- and rbfox2-targeting sbMOs are a speciﬁc
result of knockdown of Rbfox proteins.chemistry at 48 hpf reveals that slow muscle ﬁber thick ﬁlament morphology in rbfox2
substantially improved compared to that in embryos injected with rbfox1l/rbfox2 MOs
using Alexa-Fluor 488-conjugated phalloidin appears elongated and highly organized
d double morphants when compared to mock-injected wildtype controls and embryos
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Rbfox1l and Rbfox2 have unique and redundant roles in splicing
regulation
Our results show that disruption of splicing regulatory proteins in
zebraﬁsh embryos can provide new insights into tissue-speciﬁc alter-
native splicing patterns in vivo and their importance for early verte-
brate development. More speciﬁcally, these studies indicate that
Rbfox1l and Rbfox2 regulate partially overlapping networks of alter-
native splicing events in zebraﬁsh muscle, with individual differences
likely due to differential expression of Rbfox1l and/or Rbfox2 in spe-
ciﬁc cell or tissues, or by recruitment of regulatory co-factors that
are unique to either Rbfox protein (Kim et al., 2010). Overall, our ex-
periments demonstrate that conservation of intronic Rbfox binding
motifs is a good predictor of Rbfox-regulated alternative splicing.
However, a few muscle-speciﬁc Rbfox motif-associated alternative
exons were not demonstrably altered by rbfox1l/2 knockdown, indi-
cating that additional splicing factors may be essential in regulation
of the muscle alternative splicing program.
Myoﬁbril disorganization in rbfox1l/rbfox2 morphants contributes to
paralysis
The immotile and disorganized myoﬁbril phenotype of rbfox1l/rbfox2
double morphants is similar to that of a number of previously character-
ized zebraﬁsh mutants and morphants. Genes identiﬁed in these studies
act at multiple levels of myoﬁber development, affecting the function of
speciﬁc muscle structural proteins, myoﬁber assembly and maintenance,
and/or muscle ﬁber connections at the myotendinous junction. In rbfox
double morphants, complete paralysis and wavy myoﬁbers, with late
partial recovery of birefringence, suggest thatmyoﬁbril assembly is defec-
tive and disorganized. The defects are reminiscent of several mutants,
particularly hsp90a.1/sloth and frozen mutants (Du et al., 2008; Granato
et al., 1996; Hawkins et al., 2008). rbfox1l/rbfox2 morphant myoﬁbril
defects revealed by phalloidin staining are also similar to that of runzel
mutants (Steffen et al., 2007), tcap morphants (Zhang et al., 2009), and
troponin T morphants (Ferrante et al., 2011). Similarly, tgbf1 morphants,
which display defective linkage between the extracellular matrix and
cytoskeleton of muscle ﬁbers, possess wavy and disorganized myoﬁbrils
(Kim and Ingham, 2009). Finally, the abnormal localization of myosin
heavy chain (F59) observed in rbfox1l/rbfox2 morphants is similar to,
but more severe than F59-expressing ﬁber phenotypes that have been
observed in lbx2morphants (Ochi andWesterﬁeld, 2009) and dystrophic
mutants such as candyﬂoss/laminin a2(Hall et al., 2007). Future analyses
of additional myoﬁbrillar components will clarify the nature of the ﬁber
defects, whether slow- and fast-twitch ﬁbers are differentially affected,
and may identify key rbfox-regulated molecular targets.
The Rbfox regulatory network modulates expression of genes with impor-
tant muscle functions
Defects in skeletal and cardiac muscle upon Rbfox knockdown
may be due to a constellation of splicing alterations, of which we like-
ly have identiﬁed only a subset using the candidate gene approach. As
mentioned above, mutation of single genes can also lead to severe
muscle phenotypes, so it is possible that splicing mis-regulation of
only a few key targets could lead to paralysis and heart dysfunction.
Proteins identiﬁed so far that are regulated by the Rbfox network
include Syne1a, a Nesprin-related protein sometimes involved in
pathogenesis of Emery–Dreifuss muscular dystrophy in humans
(Zhang et al., 2007); Svil, a plasma membrane protein for which a
muscle-speciﬁc isoform has been shown to interact with F-actin in
skeletal muscle (Oh et al., 2003; Pope et al., 1998); the membrane
transporters Gabrg2 and Scn8aa (Baulac et al., 2001; Chen et al.,
2008); and the RNA binding protein Fxr1, which regulates somiteformation in frogs (Huot et al., 2005). Interestingly, recent work
showed that the completely immotile zebraﬁsh relaxed/cacnb1 null
mutant (Granato et al., 1996) is fully rescued by injection of the
muscle-speciﬁc cacnb1 isoform and not other closely related isoforms
(Schredelseker et al., 2009). Additionally, speciﬁc knockdown of the
alternatively spliced muscle-speciﬁc exon of the ubiquitously
expressed zebraﬁsh naca gene results in muscle paralysis, accompa-
nied by myoﬁbril disorganization, and pericardial edema (Li et al.,
2009), demonstrating functional relevance for the muscle-speciﬁc
naca spliced isoform. We expect that our subsequent studies will
reveal that a subset of Rbfox-regulated alternative spliced isoforms
display measurable contributions to muscle structure, integrity, and/
or activity. The ability to manipulate in vivo expression of individual al-
ternative exons in the zebraﬁsh systemwill facilitate functional evalua-
tion of these splicing events in skeletal and cardiac muscles.
Our results indicate that Rbfox proteins are major regulators of a
conserved, muscle-speciﬁc alternative splicing program that is essen-
tial for proper differentiation and function of vertebrate muscle. Evo-
lutionary conservation of muscle-enriched alternative splicing events
has also been reported by others (Bland et al., 2010), with Rbfox pro-
teins implicated as critical regulators along with members of the
MBNL and CELF families of splicing factors. Disruption of splicing net-
works mediated by the latter factors is a hallmark of myotonic dystro-
phy(Cooper et al., 2009; Du et al., 2010) and zebraﬁsh MBNL2
morphants also exhibit splicing defects and features of myotonic dys-
trophy (Machuca-Tzili et al., 2011). Mouse knockout experiments
have implicated additional splicing factors such as SF2/ASF (SFRS1)
and SC35 (SFRS2) as important contributors to alternative splicing
in muscle (Ding et al., 2004; Xu et al., 2005). The zebraﬁsh model sys-
tem offers a powerful opportunity to dissect further the contributions
of key splicing regulators and alternative exons to normal muscle dif-
ferentiation. Future high-throughput studies of Rbfox-regulated splic-
ing networks will identify additional target exons and may reveal
additional mechanisms by which Rbfox proteins inﬂuence muscle-
speciﬁc gene expression. Finally, understanding these processes in
an experimentally tractable animal model should provide important
insights into human muscle diseases.
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